Connecting biopharmas with the right preclinical cancer models and CRO partners
Showcase your models and services
Leverage our world-leading directory and marketing expertise to showcase your inventory to a large pool of biopharma researchers.
Extend your market reach
We’ll connect you with companies from Top 20 Pharma to small biotechs across the globe who are ready to use your models and services.
Generate more qualified leads
We speak to every researcher to identify their model and project needs before putting them in touch with you.
Components of the partnership:
By making data on preclinical oncology models more visible and searchable, CROs on the Repositive Cancer Models Platform are able to increase requests for studies from biopharma researchers.
The unique offerings of CROs on the Cancer Models Platform are promoted through targeted emails, webinars and events. In addition, there are avenues for collaboration such as white papers.
Better understand the market for preclinical oncology models and stay updated on emerging technologies. Repositive provides reports for CRO partners on trends within the research community, as well as consultation on how to generate new leads for preclinical studies.
Our collaboration with Repositive has been a very successful driver of growth for Nexus Pharma and we are excited to expand on it further as we add new PDX models to address unmet medical need.